National governments require economic data on the burden of influenza disease, the cost effectiveness of the vaccine, and the projected implementation costs of a maternal influenza immunization programme in their country in order to inform the allocation of limited resources and prioritization of interventions in the health sector.

The figure below outlines several guidance documents from WHO that can support countries to assess the economic and social benefits of introducing maternal influenza vaccination or to expand existing vaccination targeting pregnant women. Click on the publication icons to find more information on the respective guidance available.